Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes.

Campbell, Heather M; Khan, Nasreen; Raisch, Dennis W; Borrego, Matthew E; Sather, Mike R; Murata, Glen H.

doi:10.1016/j.diabres.2013.10.005

Record: found
Abstract: found
Article: not found

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes.

Author(s): Heather M Campbell ¹ , Nasreen Khan , Dennis W Raisch , Matthew E Borrego , Mike R Sather , Glen H Murata

Publication date (Electronic): Dec 2013

Journal: Diabetes research and clinical practice

Keywords: ACEI, ARB, Angiotensin receptor blocker, Angiotensin-converting enzyme inhibitor

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To compare angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) for end-stage renal disease (ESRD) development and all-cause mortality in veterans with macroalbuminuria and with newly documented type 2 diabetes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Diabetes Res. Clin. Pract.

Title: Diabetes research and clinical practice

ISSN (Electronic): 1872-8227

ISSN (Print): 0168-8227

Publication date (Electronic): Dec 2013

Volume: 102

Issue: 3

Affiliations

[1 ] VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, United States; University of New Mexico College of Pharmacy, Albuquerque, NM, United States. Electronic address: heather.campbell@va.gov.

Article

Publisher Item ID: S0168-8227(13)00347-1

DOI: 10.1016/j.diabres.2013.10.005

PubMed ID: 24183258

SO-VID: 38eef788-c4c6-4097-aa20-2179f727ffd0

History

Keywords: ACEI,ARB,Angiotensin receptor blocker,Angiotensin-converting enzyme inhibitor

Data availability:

Keywords: ACEI, ARB, Angiotensin receptor blocker, Angiotensin-converting enzyme inhibitor

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes.

Read this article at

Abstract

Related collections

Measurement of Glucocorticoid Receptor Signaling in Major Depression

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 73

Cited by 2